Correspondence 0001104659-23-120737 from Immunome Inc. (IMNM) (CIK 0001472012) (IMNM)
Immunome Inc. (IMNM) (CIK 0001472012)
Date: Nov. 22, 2023 · CIK: 0001472012 · Accession: 0001104659-23-120737
AI Filing Summary & Sentiment
File numbers found in text: 333-275598
Show Raw Text
CORRESP
1
filename1.htm
Immunome, Inc.
665 Stockton Drive, Suite 300
Exton, PA 19341
November 22, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Tamika N. Sheppard
Re: Immunome, Inc.
Registration Statement
on Form S-3
File No. 333-275598
Acceleration Request
Requested Date: November 27, 2023
Requested Time: 4:00 PM Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461
under the Securities Act of 1933, as amended, Immunome, Inc. hereby requests that the Securities and Exchange Commission take
appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-275598) (the “Registration
Statement”) to become effective on November 27, 2023, at 4:00 p.m. Eastern Time, or as soon as practicable thereafter.
Once the Registration
Statement has been declared effective, please orally confirm that event with Carlos Ramirez at Cooley LLP at (858) 550-6157 or Dylan Kornbluth
of Cooley LLP at (858) 550-6173. Thank you for your assistance with this matter.
Very truly yours,
Immunome, Inc.
By:
/s/ Sandra Stoneman
Sandra Stoneman
Chief Legal Officer
cc: Thomas Coll, Cooley LLP
Carlos Ramirez, Cooley LLP
Dylan
Kornbluth, Cooley LLP